Geriatric Psychiatry
Psychiatric Problems of Older Persons
Loss is ubiquitous in old age, yet prevalence of major depressive disorder (MDD) and dysthymia is lower than in younger adults
Proposed reasons
Rarity of late-onset depression
Higher mortality among depressed persons
Fewer disorders precipitated by emotional upheaval or substance abuse
Presentation of depression differs
Prominent physical complaints or cognitive changes → may mimic dementia
Suicide incidence in elders: 40/100{,}000 (highest in older White men)
Survivors’ attributions differ by gender of decedent
Male suicide → assumed physical illness
Female suicide → assumed mental illness
Close link between physical & mental health
Emotional problems worsen the course of chronic medical illness
Mental Disorders of Old Age (ECA Findings)
Most common: depressive disorders, cognitive disorders, phobias, alcohol use disorders
High risk for
Suicide
Drug-induced psychiatric symptoms
Many disorders are preventable, reversible, or ameliorable, esp. delirium & some dementias
Neuropsychological Evaluation in Elders
Comprehensive battery preferred, though multi-hour testing may be impractical
Domains & representative tests
Gross cognition: Mini-Mental State Examination (MMSE)
Intelligence: WAIS-R / WAIS-III
Basic attention: WAIS Digit Span
Processing speed: WAIS Digit Symbol, Trailmaking A, Stroop A/B
Motor dexterity: Finger tapping (right & left)
Language: Boston Naming Test; WAIS Vocabulary
Visual–perceptual/spatial: WAIS Picture Completion, Block Design; Rey–Osterrieth copy; Beery VMI
Learning & memory: 8- to 10-word list; WMS Logical Memory & Visual Reproduction; Rey–Osterrieth recall
Executive functions: Trailmaking B; Stroop C; Wisconsin Card Sorting; Verbal fluency (FAS/category); Design fluency
Psychosocial & Pharmacological Risk Factors
Psychosocial risks: loss of roles/autonomy, bereavement, health decline, isolation, finances, ↓ cognition
Drug-induced symptoms caused by
Age-related pharmacokinetic changes
Excess dose / non-adherence / poly-prescribing
Hypersensitivity
Nearly entire spectrum of psychiatric disorders can be drug-induced
Dementing Disorders
Second only to arthritis as a cause of disability >65 y
Prevalence ≥65 y: severe dementia 5\%; mild 15\%
≥80 y: severe \approx 20\%
Risk factors: age, family history, female sex
Clinical picture
Gradual loss of previously attained functions
Cognitive, memory, language, visuospatial deficits; behavioral issues (agitation, wandering, disinhibition, sleep issues, delusions/hallucinations in \approx 75\%)
Potentially treatable in 10\text{–}15\% (e.g.
Systemic: heart, renal, CHF
Endocrine: hypo-thyroid
Vit.
Drug misuse
Depression)
Cortical vs. subcortical classification
Subcortical: Huntington, Parkinson, NPH, vascular, Wilson → movement disorders, gait apraxia, apathy, akinetic mutism (may mimic catatonia)
Cortical: Alzheimer, CJD, Pick → aphasia, agnosia, apraxia
Prion diseases
Familial CJD, Gerstmann–Sträussler–Scheinker, fatal familial insomnia (AD inheritance, PRNP mutation)
Acquired: kuru (Fore cannibalism), iatrogenic (grafts, cadaveric hormones)
Sporadic CJD: \approx 1/1{,}000{,}000 annually; mean onset 65 y; rare <30 y
Depressive Disorders in the Elderly
Prevalence: \approx 15\% of community & nursing-home elders have depressive symptoms
Risk factors: widowhood, chronic medical illness (age per se not a risk)
High recurrence in late-onset cases
Symptoms: ↓ energy/concentration, sleep fragmentation (esp. early awakening), ↓ appetite, weight loss, somatic focus
Melancholic features more common: hypochondriasis, worthlessness, sex/sin guilt, paranoia, suicidality
Depression-related cognitive dysfunction (“pseudodementia”)
Occurs in \approx 15\% of depressed elders
Distinguish from degenerative dementia
Variable attention; “I don’t know” responses; recognition > free recall; minimal language impairment/confabulation
Yet 25\text{–}50\% of neurodegenerative dementia patients are concurrently depressed
Geriatric Depression Scale (15-item short form); score >5 ⇒ probable depression
Schizophrenia
Typically begins in youth; first diagnosis >65 y rare
Late-onset (after 45 y) described; more common in women; predominantly paranoid subtype
Prognosis
20\% symptom-free by 65 y
80\% residual impairment; psychopathology diminishes with age
Residual subtype in \approx 30\% (negative symptoms dominate) → often requires long-term hospitalization
Elders respond to antipsychotics but need lower doses
Delusional Disorder
Onset usually 40–55 y but possible at any geriatric age
Forms
Persecutory (most common): spying, poisoning, harassment → potential violence or reclusiveness
Somatic: conviction of fatal illness
Prevalence of pervasive persecutory ideation >65 y: \approx 4\%
Triggers: spousal death, retirement, isolation, finance, medical illness, sensory loss
Rule out dementia, mood disorders, schizophrenia, substance/med-induced, tumors
Prognosis fair–good; best with psychotherapy + pharmacotherapy
Paraphrenia: late-onset persecutory delusions (>60 y) without dementia; possibly schizophrenia variant; ↑ if FHx schizophrenia
Anxiety Disorders
1-month prevalence ≥65 y: 5.5\% (ECA)
Phobias: 4\text{–}8\% (most common)
Panic disorder: 1\% (new-onset rare)
Impact: milder signs yet equally or more disabling due to mobility limits
Existential factors: confronting mortality; Erikson’s integrity vs. despair
PTSD more severe owing to comorbid physical illness
Obsessive-Compulsive Disorders
OCD may first appear in late life, though many had obsessive-compulsive personality traits earlier
Features: ego-dystonic rituals/obsessions → rigidity, checking, orderliness
Somatic Symptom Disorders
Somatic complaints common: >80\% of >65 y have ≥1 chronic illness (arthritis, CV disease)
After 75 y: 20\% have diabetes; average 4 chronic conditions
Hypochondriasis prevalent >60 y (peak 40–50 y); chronic, guarded prognosis
Management: frequent but low-risk examinations; validate pain; avoid unnecessary invasive tests; employ psychologic/pharm interventions
Alcohol & Substance Use Disorders
Alcohol dependence often longstanding from youth/midlife
Typical elder drinker: medically ill (liver), divorced/widowed/never-married male, arrests, homelessness, Wernicke–Korsakoff
Nursing home prevalence: 20\% alcohol dependence
Overall, substance disorders = 10\% of geriatric emotional problems; hypnotic, anxiolytic, narcotic dependence under-recognized
Presentation: confusion, poor hygiene, depression, malnutrition, falls, exposure
Hospital delirium → often alcohol withdrawal
Consider abuse in chronic GI issues
OTC misuse: analgesics (35 %), laxatives (30 %); nicotine, caffeine
Sleep Disorders in Late Life
Age is main risk factor; elders report ↓ sleep quality, ↑ daytime naps, ↑ hypnotic use
Higher rates of
Breathing-related sleep disorder
Medication-induced movement disorders
Primary sleep disorders
Dyssomnias: primary insomnia, nocturnal myoclonus, restless legs, sleep apnea
Parasomnias: REM sleep behavior disorder (almost exclusively older men)
Contributing factors: pain, nocturia, dyspnea, GERD, lack of routine, institutionalization, alcohol
Pharmacologic caveats: monitor for anterograde amnesia, residual sedation, rebound insomnia, gait instability
Sleep architecture changes ≥65 y
REM: redistributed, ↑ episodes, shorter duration, ↓ total REM
NREM: ↓ delta amplitude, ↓ stages 3–4, ↑ stages 1–2, ↑ awakenings
Circadian: ↓ amplitude, 12-h sleep-propensity rhythm, shorter cycles; ↓ melatonin, altered adenosine response
Suicide Risk in the Elderly
Highest of any age group; white men >65 y have rate ≈5\times general population
Reasons reported by suicidal elders
\approx 33\% loneliness
\approx 10\% each: finances, poor health, depression
Demographics
Completions: 60\% male; attempts: 75\% female
Methods: completions → firearms/hanging; attempts → 70\% overdose, 20\% cutting
Most completers had unrecognized psychiatric disorder (mainly depression)
Precipitants: illness & loss (elders) vs. job/finance/family (younger)
Many communicate intent; clinicians must inquire directly—no evidence of iatrogenic suggestion
Other Common Geriatric Conditions
Vertigo
Common → activity avoidance/fear of falls
Etiologies: anemia, hypotension, arrhythmia, cerebrovascular, basilar insufficiency, ear disease, acoustic neuroma, benign positional vertigo, Ménière
Often psychological component; assess secondary gain
Anxiolytic overuse ⇒ dizziness
Tx: meclizine 25\text{–}100\,\text{mg}/day
Syncope
Mechanism: transient cerebral hypoperfusion → LOC
Requires full medical work-up
Causes (Table 25-6)
Cardiac: structural (aortic stenosis, mitral prolapse/regurgitation, HCM, myxoma); electrical (tachy-, brady-arrhythmias, block, sick sinus); ischemia/infarct
Situational hypotension: dehydration, orthostatic, postprandial, micturition, defecation, cough, swallow
Reflex: carotid sinus, vasovagal
Drugs: vasodilators, CCBs, diuretics, \beta-blockers
CNS: cerebrovascular insuff., seizures
Metabolic: hypoxemia, glucose extremes, anemia
Pulmonary: COPD, pneumonia, PE
Hearing Loss
Prevalence
≥65 y: \approx 30\%
≥75 y: \approx 50\%
Clue: “I can hear but not understand.” Most benefit from hearing aids
Elder Abuse
Affects \approx 10\% >65 y
Defined (AMA): act/omission causing harm/threatened harm
Physical, psychological, financial, material, sexual abuse; neglect (withholding necessities)
Victims: very old, frail, co-reside with often dependent abuser; both parties minimize
Interventions: legal, housing, medical, psychiatric, social services
Spousal Bereavement
Widowhood prevalence ≥65 y: women 51\%, men 14\%
Highly stressful; depressive sx peak within months, usually decline ≤1 y
↑ Mortality among survivors; highest in those with psychiatric illness or spouse’s suicide
Psychopharmacological Treatment Principles
Goals: improve quality of life, keep patients in community, postpone nursing-home placement
Pre-treatment assessment: full medical exam + ECG; collect all current meds (polypharmacy)
Dosing guidelines
Divide total daily dose (3–4×) to avoid peaks (except bedtime dosing for hypnotic effect)
Use liquids if swallowing issues
Monitor BP, pulse, side-effects
Frequent reassessment; attempt washout & baseline re-eval when possible
Epidemiology of drug use
≥65 y: highest medication users (25 % of Rx’s)
\approx 250{,}000 U.S. hospitalizations/yr from adverse drug reactions
Psychotropics, CV, diuretics most common; 40 % of hypnotics dispensed to >75 y
OTC usage: 70\% elders vs. 10\% young adults
Pharmacokinetic considerations
↓ renal & hepatic clearance (renal, liver, CV disease)
↓ gastric acid affects absorption
Body composition: ↓ lean, ↑ fat → prolonged action of lipid-soluble drugs
Altered receptor sensitivity (e.g., ↑ orthostatic hypotension)
Core rule: “Start low, go slow.” Use minimal effective dose; know interactions
Psychotherapy for Geriatric Patients
Modalities: insight-oriented, supportive, cognitive, group, family; psychoanalysis possible if appropriate
Targets age-related issues
Adapting to multiple losses (friends, roles)
New roles (retirement)
Acceptance of mortality
Benefits
↑ interpersonal functioning, self-esteem, confidence
↓ helplessness, anger; ↑ quality of life
Can improve physical sx (e.g., urinary incontinence, gait, alertness) even in cognitively impaired
Therapeutic stance
More active, supportive, flexible; anticipate need to liaise with physicians/family when incapacity arises
Elders may idealize therapist; gradual collaboration encouraged; sometimes therapist must maintain an idealized role to permit progress.